Etofibrate NEW
| Price | $39 | $49 | $78 |
| Package | 25mg | 50mg | 100mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2024-11-19 |
Product Details
| Product Name: Etofibrate | CAS No.: 31637-97-5 |
| Purity: 99.42% | Supply Ability: 10g |
| Release date: 2024/11/19 |
Product Introduction
Bioactivity
| Name | Etofibrate |
| Description | Etofibrate is a combination of clofibrate and niacin, used to treat hyperlipemia. |
| In vitro | Administering 200 mg/kg of Etofibrate results in significant inhibition of neointimal proliferation of smooth muscle cells in a rabbit model of atherosclerosis, leading to less pronounced plaque expansion. Additionally, 1.2 mM/g of Etofibrate lowers plasma free fatty acid (FFA) levels in male Sprague-Dawley rats. The effect of Etofibrate on plasma glycerol levels varies depending on the dosage and duration of treatment, either increasing or decreasing these levels. |
| In vivo | Etofibrate significantly reduces the concentration of cholesterol, triglycerides, free fatty acids, and glycerol, in both total and unesterified forms, in the microsomal fraction of rat liver plasma. It increases the activity of glycerol-3-phosphate dehydrogenase in hepatocytes, which leads to a reduction in the activities of microsomal HMG-CoA reductase and cholesterol 7α-hydroxylase without affecting acyl CoA: cholesterol acyltransferase. Moreover, etofibrate boosts the activity of cytosolic glyceraldehyde-3-phosphate dehydrogenase and the overall concentration of carnitine in rat liver, consequently lowering the concentrations of triglycerides and cholesterol. When fed rats' epididymal adipose tissue is cultured under basal conditions, etofibrate stimulates the rate of fatty acid re-esterification. It reduces the action of lipolytic products in the liver by releasing lipolytic products from adipose tissue and through intrinsic liver metabolism. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | DMSO : 68 mg/mL (186.9 mM) H2O : < 1 mg/mL (insoluble or slightly soluble) Ethanol : 68 mg/mL (186.9 mM) |
| Keywords | Inhibitor | inhibit | Etofibrate |
| Related Compound Libraries | Bioactive Compound Library | Drug Repurposing Compound Library | Anti-Cardiovascular Disease Compound Library | NO PAINS Compound Library | Bioactive Compounds Library Max | Bioactive Lipid Compound Library | Human Metabolite Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $45.00/1KG |
VIP4Y
|
Hebei Lingding Biotechnology Co., Ltd.
|
2021-09-03 | |
| $1.10/1g |
VIP4Y
|
Dideu Industries Group Limited
|
2021-08-09 | |
| $0.00/1KG |
VIP6Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2020-05-08 | |
| $1.00/1KG |
VIP7Y
|
Career Henan Chemical Co
|
2018-08-20 |
United States- Since: 2011-01-07
- Address: 36?Washington?Street, Wellesley?Hills
INQUIRY